Clinical Trial Update: Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients

View source ↗

Summary

Clinical trial NCT06153641 investigates cytokeratin 18 as a non-invasive biomarker for liver transplant rejection; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Failure
• Liver Transplant Rejection

Snippet

Sponsor: St. Louis University | Conditions: Liver Transplant Rejection, Liver Transplant Failure and Rejection | Status: ACTIVE_NOT_RECRUITING